# Nivo40-AVD for Advanced Classic Hodgkin Lymphoma

> **NCT06984146** · PHASE2 · RECRUITING · sponsor: **National Medical Research Radiological Centre of the Ministry of Health of Russia** · enrollment: 54 (estimated)

## Conditions studied

- Hodgkin Lymphoma, Adult

## Interventions

- **DRUG:** Nivolumab
- **DRUG:** Doxorubicin
- **DRUG:** Vinblastine
- **DRUG:** Dacarbazine

## Key facts

- **NCT ID:** NCT06984146
- **Lead sponsor:** National Medical Research Radiological Centre of the Ministry of Health of Russia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2028-01
- **Final completion:** 2029-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06984146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06984146, "Nivo40-AVD for Advanced Classic Hodgkin Lymphoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06984146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*